medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2023, Number 4

<< Back Next >>

Acta Pediatr Mex 2023; 44 (4)

Pediculosis: breaking the stigma. Updates on its prevention and treatment

Lomelí VR, García RMT

Language: Spanish
References: 41
Page: 328-336
PDF size: 254.01 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Durden LA, Musser GG. The sucking lice (insecta, Anoplura)of the world: a taxonomic checklist with records of mammalianhosts and geographical distributions, AmMuseum-NaturalHistory 1996; 218 (1): 12-49.

  2. Pratt HD, Litting KS, Gratz NG. Release: Human Lice ofpublic health importance, Comunicable Disease Center,1961; 74:8265

  3. Melnking TL, Burkhart CG, Burkhart CN. Ectoparasiticdiseases in dermatology: reassessment of scabies andpediculosis. Advances in Dermatology 1999; 15 (1): 67-108

  4. Nolt D, Moore S, Yan AC, Melnick L. AAP Committee on InfectiousDiseases, Committee on Practice and AmbulatoryMedicine, Section on Dermatology. Head Lice. Pediatrics2022; 150 (4): e2022059282

  5. Scanni G, Bonifazi E. Viability of the head louse eggs inpediculosis capitis. A dermatoscopy study. Eur J PediatDermatol 2016; 201 (4): 20-26.

  6. Quiroz-Herbert MA, Reyes Hernández KL, Sánchez-ChavezNP, Reyes-Gómez U, Hernández-Lira S, Reyes-Hernández D.Pediculosis. Bol Clin Hosp Infant Edo Son 2015; 32 (1): 22-25.

  7. Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, PappasG. Worldwide Prevalence of Head Lice. Emerg Infect Dis2008; 14 (9): 1493-4.

  8. Johnston JS, Yoon KS, Strycharz JP, Pittendrigh BR, Clark JM.Body lice and head lice (Anoplura: Pediculidae) have thesmallest genomes of any hemimetabolous insect reportedto date. J Med Entomol 2007; 44 (6): 1009-12.

  9. Cummings C, Finlay JC, MacDonald NE. Head lice infestations:A clinical update. Pediatrics & Child Health 2018;23 (1): e18-e24.

  10. Light JE, Toups MA, Reed DL. What’s in a name: the taxonomicstatus of human head and body lice. Mol PhylogenetEvol 2008; 47: 1203-16.

  11. Cummings C. Head lice infestations: A clinical update.Paediatr Child Health 2004; 9(9): 647-57.

  12. Alarcón-Hernández H, Hinostroza-Da-Conceicao D, Santamaria-G V. Pediculosis pubis presentación de un caso. RevCent Dermatol Pascua 2001;10 (3): 130-34.

  13. Rodríguez JH, Díaz CJ. Tricorrexis nudosa adquirida. RevAsoc Colomb Dermatol 2016; 24 (2):138-40.

  14. López-García JS, García-Lozano I, Martínez Garchitorena J.Phthiriasis palpebral: diagnóstico y tratamiento. Archivosde la Sociedad Española de Oftalmología 78 (7): 365-74.

  15. Lokhande AJ, Soni R, Dhali TK. Macula Ceruleae with HeadLouse. Indian Dermatol Online J 2019; 10 (4): 492-93.

  16. Barker SC, Barker D. Killing. Clothes Lice by Holding InfestedClothes Away from Hosts for 10 Days to Control LouseborneRelapsing Fever, Bahir Dah, Ethiopia. Emerg Infect Dis 2019;25 (2): 304-10.

  17. Fu YT, Yao C, Deng YP. Human pediculosis, a global publichealth problem. Infect Dis Poverty 2022; 11 (1): 58-64.

  18. Nutanson I, Steen C, Schwartz RA. Pediculosis corporis: anancient itch. Acta Dermatovenerol Croat 2007; 15: 33-8.

  19. Leung AKC, Lam JM, Leong KF, Barankin B, Hon KL. Pediatrics:how to manage pediculosis capitis. Drugs Context 2022; 14 (11): 11-13.

  20. González-Rivera A, Rosas-Ruiz A, Hernández-Martínez,Victoria-Rodríguez C, Hernández-Hernández D, Bolaños-Rodríguez E, et al. Comunicado: Plan de prevención y controlde infecciones. Instituto Nacional de Pediatría, 2015.

  21. Ahmad HM, Abdel-Azim ES, Abdel-Aziz RT. Assessment oftopical versus oral ivermectin as a treatment for head lice.Dermatol Ther 2014; 27 (5): 307-10.

  22. Flinders DC, De-Schweinitz P. Pediculosis and scabies. AmFam Physician 2004; 15; 69 (2): 341-8.

  23. Burkhart CN. Fomite transmission with head lice: A continuingcontroversy. Lancet 2003; 361 (9352): 99-100.

  24. Johnson J. Pyrethrins versus Pyrethroids: what’s the difference?2021: EPA-HQ-OPP-2011-0885

  25. Durand R, Bouvresse S, Berdjane Z, Izri A, Chosidow O,Clark JM. Insecticide resistance in head lice: clinical,parasitological and genetic aspects. Clin Microbiol Infect2012; 18 (4): 338-44.

  26. Meinking TL, Entzel P, Villar ME, Vicaria M, Lemard GA,Porcelain SL. et al. Comparative efficacy of treatmentsfor pediculosis capitis infestations: update 2000. ArchDermatol 2001; 137 (3): 287-92.

  27. Lebwohl M, Clark L, Levitt J. Therapy for head lice based onlife cycle, resistance, and safety considerations. Pediatrics2007; 119 (5): 965-74.

  28. Durand R, Bouvresse S, Berdjane Z, Izri A, Chosidow O,Clark JM. Insecticide resistance in head lice: clinical, parasitologicaland genetic aspects, Clinical Microbiology andInfection 2012;18(4):7-14

  29. Seiler JC, Keech RC, Aker JL. Spinosad at 0.9% in thetreatment of scabies: Efficacy results from 2 multicenter,randomized, double-blind, vehicle-controlled studies. J AmAcad Dermatol. 2022;86(1):97-103.

  30. Deeks LS, Naunton M, Currie MJ, Bowden FJ. Topicalivermectin 0.5% lotion for treatment of head lice. AnnPharmacother. 2013;47(9):1161–1167

  31. Burgess IF, Brown CM, Lee PN. Treatment of head louse infestationwith 4% dimeticone lotion: randomized controlledequivalence trial. BMJ. 2005; 330(7505):1423

  32. Pollack RJ. Head lice infestation: Single drug versus combinationtherapy. Pediatrics 2001;108(6):1393.

  33. Barker SC, Altman PM. A randomized, assessor blind,parallel group comparative efficacy trial of threeproducts for the treatment of head lice in childrenmelaleuca oil and lavender oil, pyrethrins and piperonylbutoxide, and a “suffocation” product. BMC Dermatol.2010;10(6):6-10

  34. Bonanno M, Lee OS, Sayed C. Decreases in scabies and licecases among the pediatric and adult populations duringCOVID-19. Pediatr Dermatol. 2022;39(5):737-739.

  35. Hurst SK, Dotson JAW, Butterfield P, Corbett CF, Oneal G.Stigma resulting from head lice infestation: A conceptanalysis and implications for public health. Nurs Forum.2020;1:1–7.

  36. Coates SJ, Thomas C, Chosidow O, Engelman D, Chang AY.Part II – Ectoparasites: Pediculosis and Tungiasis, J Am AcadDermatol 2020 Mar;82(3):551-569

  37. Unidad de Medicina Preventiva. SESCAM. Comunicado:Actuaciones ante pacientes con pediculosis. HospitalVirgen de la Luz, España. 2006

  38. Diagnóstico y tratamiento de pediculosis capitis en escolaresy adolescentes. México: Instituto Mexicano delSeguro Social: 2013

  39. Norma Oficial Mexicana NOM-045-SSA2-2005, Para lavigilancia epidemiológica, prevención y control de las infeccionesnosocomiales. Secretaría de Salud, México, 2005

  40. Norma Oficial Mexicana NOM-032-SSA2-2010, Para lavigilancia epidemiológica, prevención y control de las enfermedadestransmitidas por vector. Secretaría de Salud,México, 2010

  41. Cristerna Tarrasa GH, Hernández-Orozco H, Arias de laGarza E, González Saldaña N. Actualización de las precaucionesestándar y específicas de aislamiento para laprevención de las infecciones asociadas a la atención ensalud. Acta Pediatr Méx 2021; 42 (2): 74-84




2020     |     www.medigraphic.com